American Oriental Bioengineering Announces Participation in November Investor Conferences
October 31 2008 - 9:00AM
PR Newswire (US)
NEW YORK, Oct. 31 /Xinhua-PRNewswire-FirstCall/ -- American
Oriental Bioengineering, Inc. (NYSE:AOB) ("AOBO"), a leading
marketer, distributor and manufacturer of pharmaceutical and
healthcare products in China, today announced that the Company will
present at the following conferences: -- Oppenheimer 19th Annual
Healthcare Conference, held at the Waldorf- Astoria in New York.
Management is currently scheduled to present at 8:40 am ET on
Tuesday, November 4, 2008. -- Credit Suisse Asia Healthcare
Conference, held at the Westin in Beijing. Management is currently
scheduled to present at 4:30 pm local time on Wednesday, November
5, 2008; -- Morgan Stanley 2008 Asia Pacific Summit, held at the
Mandarin Oriental in Singapore. Management is currently scheduled
to present at 3:15 pm local time on Wednesday, November 12, 2008;
-- Oppenheimer 4th Annual 'Best Ideas' Conference, held at the
Millennium Broadway in New York. Management is currently scheduled
to present at 1:20 pm ET on Tuesday, November 18, 2008. A webcast
of this presentation will be available via the Company's website at
http://www.bioaobo.com/ . -- Lazard 5th Annual Healthcare
Conference, held at the St. Regis in New York. Management is
currently scheduled to present at 11:30 am ET on Wednesday,
November 19, 2008. For more details on the conferences, please
contact your respective institutional sales representative. About
American Oriental Bioengineering Inc. American Oriental
Bioengineering Inc. is a pharmaceutical company dedicated to
improving health through the development, manufacture and
commercialization of a broad range of prescription and over the
counter products in China. Statements made in this press release
are forward-looking and are made pursuant to the safe harbor
provisions of the Securities Litigation Reform Act of 1995. Such
statements involve risks and uncertainties that may cause actual
results to differ materially from those set forth in these
statements. The economic, competitive, governmental, technological
and other factors identified in the Company's filings with the
Securities and Exchange Commission, including the Form 10-Q for the
quarter ended June 30, 2008, may cause actual results or events to
differ materially from those described in the forward looking
statements in this press release. The Company undertakes no
obligation to publicly update or revise any forward-looking
statements, whether because of new information, future events, or
otherwise. DATASOURCE: American Oriental Bioengineering Inc.
CONTACT: Ashley M. Ammon of Integrated Corporate Relations,
+1-203-682-8200, for AOB Web Site: http://www.bioaobo.com/
Copyright
American Oriental Bioengineering, Inc. (NYSE:AOB)
Historical Stock Chart
From Jun 2024 to Jul 2024
American Oriental Bioengineering, Inc. (NYSE:AOB)
Historical Stock Chart
From Jul 2023 to Jul 2024